SCHEMBL7307870

SCHEMBL7307870

CCCn1nc(C)c(C(N)=O)c1-c1cc(S(=O)(=O)N2CCN(C)CC2)ccc1OCC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 15/20 0.59
PDE1A P54750 5/20 0.59
PDE1B Q01064 5/20 0.59
PDE1C Q14123 5/20 0.59
CA12 O43570 5/20 0.53
CA9 Q16790 5/20 0.53
CA1 P00915 3/20 0.51
PDE4B Q07343 2/20 0.51
PDE2A O00408 1/20 0.47
ABCC4 O15439 1/20 0.47
ABCC5 O15440 1/20 0.47
PDE6D O43924 1/20 0.47
PDE8A O60658 1/20 0.47
PDE9A O76083 1/20 0.47
ABCB11 O95342 1/20 0.47
CYP3A4 P08684 1/20 0.47
HTR1A P08908 1/20 0.47
PDE6A P16499 1/20 0.47
PDE6G P18545 1/20 0.47
PDE4A P27815 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7310252 0.84 PDE5A (0.50) PDE5APDE1APDE1BPDE1CCA12
SCHEMBL6197039 0.82 KMT2A (0.53) PDE5APDE1APDE1BPDE1CCA12
SCHEMBL7304817 0.81 PDE5A (0.56) PDE5APDE1APDE1BPDE1CCA12
SCHEMBL5875796 0.76 MEN1 (0.60)
SCHEMBL6198473 0.75 PDE5A (1.00) PDE5APDE1APDE1BPDE1CPDE4B
SCHEMBL12047459 0.71 CA12 (0.77) PDE5APDE1APDE1BPDE1CCA12
SCHEMBL6201352 0.71 KMT2A (0.51) PDE5APDE1APDE1BPDE1CCA12
SCHEMBL5827157 0.71 CYP2C9 (0.65) CA12CA9
SCHEMBL5875625 0.71 TSHR (0.57) PDE5ACA12CA9
SCHEMBL4551788 0.70 POLB (0.60) PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407114-B1 BENIGN PROSTATIC HYPERPLASIA, CARDIOVASCULAR, GASTROINTESTINAL AND RESPIRATORY DISORDER TREATMENT; ANTIASTHMATIC, ANTIALLERGEN, AND ANTIDIABETIC AGENTS PFIZER INC. 2002-06-18 US disclosed
EP-0995751-A2 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction PFIZER INC. (US) 2000-04-26 EP disclosed